Literature DB >> 15045612

Treatment of intracerebral hemorrhage: the clinical evidences.

R Sterzi1, S Vidale.   

Abstract

Of all strokes 10% to 15% are intracerebral hemorrhage, primary ICH accounting for more than 75% of cases. A correct evaluation and management must start in the emergency room, in particular for patients who rapidly deteriorate. The diffusion of organized care for stroke patients and the availability of the stroke units in Italian hospitals, may represent a further opportunity to improve the outcome of patients with ICH. Despite the bulk of evidences coming from the randomized clinical therapeutic trials for acute ischemic stroke, the available data for randomized surgical trials are scanty. In these small randomized studies, neither surgical nor medical treatment has conclusively been shown to benefit patients with ICH. Surgical techniques are improving but it is important to find out the time window during which surgical evacuation is most effective with respect to the long-term outcome. The use of thrombolytic therapy to promote the resolution of ventricular blood clots appears to be promising.

Entities:  

Mesh:

Year:  2004        PMID: 15045612     DOI: 10.1007/s10072-004-0208-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  1 in total

1.  NF-κB activation and cell death after intracerebral hemorrhage in patients.

Authors:  Zeli Zhang; Yuguang Liu; Qibing Huang; Yuxing Su; Yuan Zhang; Guanghui Wang; Feng Li
Journal:  Neurol Sci       Date:  2014-02-08       Impact factor: 3.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.